Practical timeline expectations For researchers who decide to proceed with a combined protocol despite the unknown risks, realistic timeline expectations help set appropriate milestones for evaluation
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) effectively manage type 2 diabetes and promote weight loss, but their gastrointestinal effectsincluding nausea, vomiting, and diarrheacan disrupt fluid and electrolyte balance
BrAC levels in the GLP-RA group were not different from controls by 1 h post drinking
The immunohistochemical analysis procedure was the same as that used in our previous study (16), in which we examined GLP-1R expression in PNETs and found no significant associations between the receptor expression status and several clinicopathological characteristics
We don't believe in fillers or synthetic additives
"Food could potentially remain in the stomach longer, increasing the risk of aspiration and pneumonia if it enters the windpipe during procedures." In response to these concerns, the American Society of Anesthesiologists recommended that patients discontinue GLP-1 agonists at least seven days before any surgery or endoscopy